Endocrine-Related Cancer

2.1K posts

Endocrine-Related Cancer banner
Endocrine-Related Cancer

Endocrine-Related Cancer

@EndoCancer

Publishing translational & clinical investigations of human health & disease focusing on #endocrine neoplasias & hormone-dependent #cancers. Owned by @soc_endo.

Katılım Ağustos 2014
1.5K Takip Edilen3.3K Takipçiler
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
New research by Exequiel Gonzalo Alonso et al. uncovers a protumor role for HO-1 in thyroid cancer by enhancing proliferation, migration & cell cycle progression. 🔎 🎯Could HO-1 be a therapeutic target? Subscribers can read the research: doi.org/10.1530/ERC-25…
Endocrine-Related Cancer tweet media
English
1
0
0
97
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
🧠Contribute to Endocrine-Related Cancer's new Special Collection on pituitary tumours! We welcome basic, translational & clinical studies that advance understanding & showcase innovations. 📩Submit your proposal to: erc@bioscientifica.com 🌐More info: bit.ly/4mUXslc
Endocrine-Related Cancer tweet media
English
0
1
2
168
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
🎯Targeting RET in medullary thyroid cancer has played a key role in therapeutic strategies in the past decade. A new review by Kate Newbold and Leslie Cheng explores targeted and selective RET therapies, and highlights the challenge of resistance. 🔗doi.org/10.1530/ERC-24…
Endocrine-Related Cancer tweet media
English
0
0
1
140
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
🌟We are delighted to announce that Prof. Alfred Lam, Professor of Pathology at @Griffith_Health, has joined Endocrine-Related Cancer's editorial board as an Associate Editor. Explore his recent research article on the rising incidence of thyroid cancer: doi.org/10.1530/ERC-24…
Endocrine-Related Cancer tweet media
English
0
0
0
118
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
🎯Could DNA-PKcs be a potential target for differentiated thyroid cancer therapy? Recent preclinical research by Shu-Fu Lin et al. reveals that M3814, a DNA-PKcs inhibitor, has significant potential in treating DTC. 🔗Explore the results: doi.org/10.1530/ERC-25…
Endocrine-Related Cancer tweet media
English
0
0
1
104
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
How do treatments for neuroendocrine neoplasms impact quality of life? A new review explores the impact of existing therapies such as somatostatin analogs, radioligand therapy, multikinase inhibitors & chemotherapy on QoL in NEN survivors. 📖 Read more: doi.org/10.1530/ERC-24…
Endocrine-Related Cancer tweet media
English
0
0
2
159
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
✨We are thrilled to welcome Dr. Karel Pacak as the incoming Editor-in-Chief of Endocrine-Related Cancer! Dr. Pacak's term begins on 1st January 2026. We are excited for this next chapter, driven by his expertise and vision🚀
Endocrine-Related Cancer tweet media
English
0
0
2
109
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
🧪New research by Jinheng Xiao et al. explores the distinct metabolic profiles of parathyroid carcinoma and parathyroid adenoma, identifying promising biomarkers for preoperative diagnosis of parathyroid carcinoma. Read the full article #OpenAccess: doi.org/10.1530/ERC-24…
Endocrine-Related Cancer tweet media
English
0
0
1
121
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
📢Are you attending #ENDO2025? Come and visit the Bioscientifica booth, 803, to find out more about publishing in Endocrine-Related Cancer!🙌✨
Endocrine-Related Cancer tweet media
English
0
1
4
238
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
🆕Endocrine-Related Cancer is now on Bluesky. Join us to stay up-to-date with research updates and news from Endocrine-Related Cancer, including the latest articles and developments in endocrine oncology. 🦋bsky.app/profile/endoca…🦋
Endocrine-Related Cancer tweet media
English
0
0
0
72
Endocrine-Related Cancer
Endocrine-Related Cancer@EndoCancer·
We’re proud to share a message from our Editor-in-Chief following the news of our increased Journal Impact Factor, placing Endocrine-Related Cancer in Q1 for both 'Endocrinology & Metabolism' and 'Oncology' categories! 👇
Endocrine-Related Cancer tweet media
English
0
0
0
114